Unknown

Dataset Information

Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.


ABSTRACT:

Background

The impact of the coronavirus disease 2019 (COVID-19) pandemic on cancer screening participation is a global concern. A national database of screening performance is available in Japan for population-based cancer screening, estimated to cover approximately half of all cancer screenings.

Methods

Utilizing the fiscal year (FY) 2017-2020 national database, the number of participants in screenings for gastric cancer (upper gastrointestinal [UGI] series or endoscopy), colorectal cancer (fecal occult blood test), lung cancer (chest X-ray), breast cancer (mammography), and cervical cancer (Pap smear) were identified. The percent change in the number of participants was calculated.

Results

Compared with the pre-pandemic period (FY 2017-2019), in percentage terms FY

SUBMITTER: Machii R 

PROVIDER: S-EPMC9726684 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature